The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI

EuroIntervention 2017;13:e1392-e1400 published online September 2017 published online e-edition December 2017. DOI: 10.4244/EIJ-D-17-00198

1. Dipartimento di Scienze Mediche, Divisione di Cardiologia, Città della Salute e della Scienza, Turin, Italy; 2.Bristol Heart Institute, University of Bristol, School of Clinical Sciences, Bristol, United Kingdom; 3. A.O.U San Luigi Gonzaga, Division of

Aims: The safety and efficacy of single vs. dual antiplatelet therapy (DAPT) in patients undergoing TAVI remain to be addressed. The aim of our study was to evaluate the usefulness of a D

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Transcatheter mitral valve replacement with the NaviGate stent in a preclinical model